Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2017
Price : $35 *
At a glance
- Drugs Immune globulin (Primary)
- Indications Necrosis; Soft tissue infections
- Focus Therapeutic Use
- Acronyms INSTINCT
- 29 Sep 2016 Status changed from active, no longer recruiting to completed.
- 02 Mar 2016 Planned End Date changed from 1 Oct 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov.
- 02 Mar 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Sep 2016 as reported by ClinicalTrials.gov.